Impax Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IMPAX LABS, and what generic and branded alternatives to IMPAX LABS drugs are available?
IMPAX LABS has one hundred and forty approved drugs.
There are four tentative approvals on IMPAX LABS drugs.
Drugs and US Patents for Impax Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Impax Labs Inc | MINOCYCLINE HYDROCHLORIDE | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 090024-003 | Feb 3, 2009 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Impax Labs | PROBENECID AND COLCHICINE | colchicine; probenecid | TABLET;ORAL | 083720-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Impax Labs Inc | MORPHINE SULFATE | morphine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 200411-001 | Apr 12, 2016 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for IMPAX LABS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.